Home / Health / India's First Indigenous Bird Flu Vaccine Developed

India's First Indigenous Bird Flu Vaccine Developed

Summary

  • India developed its first indigenous H5N1 avian influenza vaccine for chickens.
  • The vaccine targets the H5N1 Clade 2.3.2.1a strain prevalent since 2011.
  • Priced at Rs 1-2 per dose, it offers 100% protection in trials.

Scientists at the ICAR-National Institute of High Security Animal Diseases (NIHSAD) in Bhopal have successfully developed India's first indigenous vaccine against the H5N1 strain of avian influenza. This crucial development targets the H5N1 Clade 2.3.2.1a, responsible for numerous bird flu outbreaks in Indian poultry since 2011, which have led to substantial economic losses.

The vaccine, priced at an economical Rs 1-2 per dose, underwent rigorous safety and efficacy tests. Experimental trials confirmed it provides 100% protection against the targeted strain for 24 weeks post-booster vaccination and importantly, prevents virus transmission between chickens. This breakthrough aims to mitigate economic damage to the poultry sector and reduce the risk of human transmission.

While the vaccine is not yet available commercially, the technology transfer process to manufacturers is expected to begin soon. This advancement underscores India's growing capability in developing indigenous solutions for critical animal diseases, reducing dependence on foreign supplies.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

Read more news on

Property Code: 5571